Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J-C Cutz

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Synapse (New York, N.Y.)|March 1, 1996
Brain region-specific and time-dependent decreases of G alpha i2 in amygdala-kindled ratsJ C Cutz, P P Li, W M Burnham, et al.
British Journal of Cancer|April 26, 2014
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesisJ Yan, J De Melo, J-C Cutz, et al.
The European Respiratory Journal|September 4, 2007
A common presentation with a rare causeJ-C Cutz, J S Woods, J H Mitchell, et al.
Current Oncology (Toronto, Ont.)|August 25, 2015
Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?R VanderMeer, S Chambers, A Van Dam, et al.
British Journal of Cancer|April 28, 2006
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancerC-Q Zhu, J-C Cutz, N Liu, et al.
British Journal of Cancer|May 2, 2013
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPKY Storozhuk, S N Hopmans, T Sanli, et al.
Current Oncology (Toronto, Ont.)|May 12, 2017
Improving molecular testing and personalized medicine in non-small-cell lung cancer in OntarioC Lim, H S Sekhon, J C Cutz, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Synapse (New York, N.Y.)|March 1, 1996
Brain region-specific and time-dependent decreases of G alpha i2 in amygdala-kindled ratsJ C Cutz, P P Li, W M Burnham, et al.
British Journal of Cancer|April 26, 2014
Aldehyde dehydrogenase 3A1 associates with prostate tumorigenesisJ Yan, J De Melo, J-C Cutz, et al.
The European Respiratory Journal|September 4, 2007
A common presentation with a rare causeJ-C Cutz, J S Woods, J H Mitchell, et al.
Current Oncology (Toronto, Ont.)|August 25, 2015
Diagnosing lung cancer in the 21st century: are we ready to meet the challenge of individualized care?R VanderMeer, S Chambers, A Van Dam, et al.
British Journal of Cancer|April 28, 2006
Amplification of telomerase (hTERT) gene is a poor prognostic marker in non-small-cell lung cancerC-Q Zhu, J-C Cutz, N Liu, et al.
British Journal of Cancer|May 2, 2013
Metformin inhibits growth and enhances radiation response of non-small cell lung cancer (NSCLC) through ATM and AMPKY Storozhuk, S N Hopmans, T Sanli, et al.
Current Oncology (Toronto, Ont.)|May 12, 2017
Improving molecular testing and personalized medicine in non-small-cell lung cancer in OntarioC Lim, H S Sekhon, J C Cutz, et al.
Current Oncology (Toronto, Ont.)|September 25, 2019
Crizotinib inhibition of <i>ROS1-</i>positive tumours in advanced non-small-cell lung cancer: a Canadian perspectiveD G Bebb, J Agulnik, R Albadine, et al.
Pageof 1